Literature DB >> 25213554

Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence.

Wahid Boukouaci1, Laura Lauden1, Johan Siewiera2, Noemie Dam3, Hocine-Rachid Hocine1, Zena Khaznadar1, Ryad Tamouza1, Luis R Borlado4, Dominique Charron1, Nabila Jabrane-Ferrat2, Reem Al-Daccak5.   

Abstract

AIMS: Allogeneic human cardiac-derived stem/progenitor cells (hCPC) are promising candidates for cardiac repair. They interact with T cells, major effectors of the adaptive immune response, inducing 'paracrine' anti-inflammatory effects that could sustain tissue repair/regeneration. Natural killer (NK) cells are major effectors of the innate immune system that might influence the persistence of therapeutic stem/progenitor cells. Therefore, to get through successful clinical translation and anticipate allogeneic hCPC persistence, we defined their crosstalk with NK cells under steady state and inflammatory conditions. METHODS AND
RESULTS: By using an experimental model of allogeneic hCPC/NK cell interaction, we demonstrate that hCPC moderately trigger cytokine-activated, but not resting, NK cell killing that occurs through formation of lytic immunological synapse and NK cell natural cytotoxicity. Yet, inflammatory context substantially decreases their capacity to set cytokine-activated NK cell functions towards NK cell-cytotoxicity and protects hCPC from NK cell killing. Allogeneic hCPC also restrain NK cell-cytotoxicity against conventional targets and inflammatory cytokine secretion biasing the latter towards anti-inflammatory cytokines. Thus, hCPC are unprivileged targets for allogeneic NK cells and can restrain NK cell functions in allogeneic setting.
CONCLUSION: Collectively, our data suggest that allogeneic hCPC/innate NK cells crosstalk within injured inflamed myocardium would permit their retention and might contribute to attenuating inflammation and to preventing adverse cardiac remodelling. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Allogenicity; Human cardiac stem/progenitor cells; Myocardial infarction; NK cells

Mesh:

Substances:

Year:  2014        PMID: 25213554     DOI: 10.1093/cvr/cvu208

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

Review 1.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

2.  Identification of Genes Linking Natural Killer Cells to Apoptosis in Acute Myocardial Infarction and Ischemic Stroke.

Authors:  Lele Feng; Ruofei Tian; Xingdou Mu; Cheng Chen; Yuxi Zhang; Jun Cui; Yujie Song; Yingying Liu; Miao Zhang; Lei Shi; Yang Sun; Ling Li; Wei Yi
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

3.  Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair.

Authors:  Noémie Dam; Hocine Rachid Hocine; Itziar Palacios; Olga DelaRosa; Ramón Menta; Dominique Charron; Armand Bensussan; Hicham El Costa; Nabila Jabrane-Ferrat; Wilfried Dalemans; Eleuterio Lombardo; Reem Al-Daccak
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

4.  Immunological Properties of Murine Parthenogenetic Stem Cells and Their Differentiation Products.

Authors:  Hannah Johannsen; Vijayakumar Muppala; Carina Gröschel; Sebastian Monecke; Leslie Elsner; Michael Didié; Wolfram-Hubertus Zimmermann; Ralf Dressel
Journal:  Front Immunol       Date:  2017-08-04       Impact factor: 7.561

Review 5.  Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration.

Authors:  Annie Tosello-Trampont; Fionna A Surette; Sarah E Ewald; Young S Hahn
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

6.  Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Authors:  Hocine R Hocine; Hicham E L Costa; Noemie Dam; Jerome Giustiniani; Itziar Palacios; Pascale Loiseau; Armand Bensussan; Luis R Borlado; Dominique Charron; Caroline Suberbielle; Nabila Jabrane-Ferrat; Reem Al-Daccak
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

7.  Immune responses to bioengineered organs.

Authors:  Jordi Ochando; Dominique Charron; Pedro M Baptista; Basak E Uygun
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

8.  CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome.

Authors:  José Luis Torán; Susana Aguilar; Juan Antonio López; Carlos Torroja; Juan Antonio Quintana; Cesar Santiago; José Luis Abad; Patricia Gomes-Alves; Andrés Gonzalez; Juan Antonio Bernal; Luis Jesús Jiménez-Borreguero; Paula Marques Alves; Luis R-Borlado; Jesús Vázquez; Antonio Bernad
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

9.  Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D.

Authors:  Carina Gröschel; Daniela Hübscher; Jessica Nolte; Sebastian Monecke; André Sasse; Leslie Elsner; Walter Paulus; Claudia Trenkwalder; Bojan Polić; Ahmed Mansouri; Kaomei Guan; Ralf Dressel
Journal:  Front Immunol       Date:  2017-07-26       Impact factor: 7.561

Review 10.  Cardiac Progenitor Cells and the Interplay with Their Microenvironment.

Authors:  Arianna Mauretti; Sergio Spaans; Noortje A M Bax; Cecilia Sahlgren; Carlijn V C Bouten
Journal:  Stem Cells Int       Date:  2017-09-17       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.